iRHOM2-dependent regulation of ADAM17 in cutaneous disease and epidermal barrier function

Human Molecular Genetics

Volumn 23, Issue 15, 2014, Pages 4064-4076

  Brooke, Matthew A ^a   Etheridge, Sarah L ^a   Kaplan, Nihal ^b   Simpson, Charlotte ^a   O'Toole, Edel A ^a   Ishida Yamamoto, Akemi ^c   Marches, Olivier ^a   Getsios, Spiro ^b   Kelsell, David P ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b NORTHWESTERN UNIVERSITY   (United States)

^c ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DESMOGLEIN 2; GROWTH FACTOR; INTERLEUKIN 6; INTERLEUKIN 8; INVOLUCRIN; IRHOM2 PROTEIN; LORICRIN; PROTEIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; UNCLASSIFIED DRUG; ADAM PROTEIN; CARRIER PROTEIN; EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; RHBDF2 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR-ALPHA CONVERTASE;

ARTICLE; CELL FUNCTION; CELL MIGRATION; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DESMOSOME; ELECTRON MICROSCOPY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDERMIS; ESOPHAGUS CANCER; FEMALE; GENE MUTATION; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; INFECTION RESISTANCE; KERATINOCYTE; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SKIN DISEASE; SKIN FUNCTION; STAPHYLOCOCCUS INFECTION; UPREGULATION; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; ESOPHAGUS TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MICROBIOLOGY; MUTATION; PALMOPLANTAR KERATODERMA; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; STAPHYLOCOCCAL SKIN INFECTION; STAPHYLOCOCCUS AUREUS;

ADAM PROTEINS; CARRIER PROTEINS; CYTOKINES; DESMOSOMES; EPIDERMAL GROWTH FACTOR; EPIDERMIS; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; KERATINOCYTES; KERATODERMA, PALMOPLANTAR; MALE; MUTATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS; TRANSGLUTAMINASES;

EID: 84901407239     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddu120     Document Type: Article

References (77)

1. Etheridge, S.L., Brooke, M.A., Kelsell, D.P. and Blaydon, D.C. (2013) Rhomboid proteins: a role in keratinocyte proliferation and cancer. Cell Tissue Res., 351, 301-307.
2. Freeman, M. (2008) Rhomboid proteases and their biological functions. Ann. Rev. Genet., 42, 191-210.
3. Zettl, M., Adrain, C., Strisovsky, K., Lastun, V. and Freeman, M. (2011) Rhomboid family pseudoproteases use the ER quality control machinery to regulate intercellular signaling. Cell, 145, 79-91.
4. Adrain, C., Zettl, M., Christova, Y., Taylor, N. and Freeman, M. (2012) Tumor necrosis factor signaling requires iRhom2 to promote trafficking and activation of TACE. Science, 335, 225-228.
5. McIlwain, D.R., Lang, P.A., Maretzky, T., Hamada, K., Ohishi, K., Maney, S.K., Berger, T., Murthy, A., Duncan, G., Xu, H.C. et al. (2012) iRhom2 regulation of TACE controls TNF-mediated protection against Listeria and responses to LPS. Science, 335, 229-232.
6. Black, R.A., Rauch, C.T., Kozlosky, C.J., Peschon, J.J., Slack, J.L., Wolfson, M.F., Castner, B.J., Stocking, K.L., Reddy, P., Srinivasan, S. et al. (1997) A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature, 385, 729-733.
7. Moss, M.L., Jin, S.L., Milla, M.E., Bickett, D.M., Burkhart, W., Carter, H.L., Chen, W.J., Clay, W.C., Didsbury, J.R., Hassler, D. et al. (1997) Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature, 385, 733-736.
8. Sahin, U., Weskamp, G., Kelly, K., Zhou, H.M., Higashiyama, S., Peschon, J., Hartmann, D., Saftig, P. and Blobel, C.P. (2004) Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J. Cell Biol., 164, 769-779.
9. Peschon, J.J., Slack, J.L., Reddy, P., Stocking, K.L., Sunnarborg, S.W., Lee, D.C., Russell, W.E., Castner, B.J., Johnson, R.S., Fitzner, J.N. et al. (1998) An essential role for ectodomain shedding in mammalian development. Science, 282, 1281-1284.
10. Gschwind, A., Hart, S., Fischer, O.M. and Ullrich, A. (2003) TACEcleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells. EMBO J., 22, 2411-2421.
11. Bech-Serra, J.J., Santiago-Josefat, B., Esselens, C., Saftig, P., Baselga, J., Arribas, J. and Canals, F. (2006) Proteomic identification of desmoglein 2 and activated leukocyte cell adhesion molecule as substrates of ADAM17 and ADAM10 by difference gel electrophoresis. Mol. Cell Biol., 26, 5086-5095.
12. Klessner, J.L., Desai, B.V., Amargo, E.V., Getsios, S. and Green, K.J. (2009) EGFRandADAMscooperate to regulate shedding and endocytic trafficking of the desmosomal cadherin desmoglein 2. Mol. Biol. Cell, 20, 328-337.
13. Schlondorff, J., Becherer, J.D. and Blobel, C.P. (2000) Intracellular maturation and localization of the tumour necrosis factor alpha convertase (TACE). Biochem J., 347, 131-138.
14. Issuree, P.D., Maretzky, T., McIlwain, D.R., Monette, S., Qing, X., Lang, P.A., Swendeman, S.L., Park-Min, K.H., Binder, N., Kalliolias, G.D. et al. (2013) iRHOM2 is a critical pathogenic mediator of inflammatory arthritis. J. Clin. Invest., 123, 928-932.
15. Jackson, L.F., Qiu, T.H., Sunnarborg, S.W., Chang, A., Zhang, C., Patterson, C. and Lee, D.C. (2003) Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling. EMBO J., 22, 2704-2716.
16. Shi, W., Chen, H., Sun, J., Buckley, S., Zhao, J., Anderson, K.D., Williams, R.G. and Warburton, D. (2003) TACE is required for fetal murine cardiac development and modeling. Dev. Biol., 261, 371-380.
17. Christova, Y., Adrain, C., Bambrough, P., Ibrahim, A. and Freeman, M. (2013) Mammalian iRhoms have distinct physiological functions including an essential role in TACE regulation. EMBO Rep., 14, 884-890.
18. Blaydon, D.C., Biancheri, P., Di, W.L., Plagnol, V., Cabral, R.M., Brooke, M.A., van Heel, D.A., Ruschendorf, F., Toynbee, M., Walne, A. et al. (2011) Inflammatory skin and bowel disease linked to ADAM17 deletion. N. Engl. J. Med., 365, 1502-1508.
19. Franzke, C.W., Cobzaru, C., Triantafyllopoulou, A., Loffek, S., Horiuchi, K., Threadgill, D.W., Kurz, T., van Rooijen, N., Bruckner-Tuderman, L. and Blobel, C.P. (2012) Epidermal ADAM17 maintains the skin barrier by regulating EGFR ligand-dependent terminal keratinocyte differentiation. J. Exp. Med., 209, 1105-1119.
20. Chalaris, A., Adam, N., Sina, C., Rosenstiel, P., Lehmann-Koch, J., Schirmacher, P., Hartmann, D., Cichy, J., Gavrilova, O., Schreiber, S. et al. (2010) Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in mice. J. Exp. Med., 207, 1617-1624.
21. Blaydon, D.C., Etheridge, S.L., Risk, J.M., Hennies, H.C., Gay, L.J., Carroll, R., Plagnol, V., McRonald, F.E., Stevens, H.P., Spurr, N.K. et al. (2012) RHBDF2mutations are associated with tylosis, a familial esophageal cancer syndrome. Am. J. Hum. Genet., 90, 340-346.
22. Saarinen, S., Vahteristo, P., Lehtonen, R., Aittomaki, K., Launonen, V., Kiviluoto, T. and Aaltonen, L.A. (2012) Analysis of a Finnish family confirms RHBDF2 mutations as the underlying factor in tylosis with esophageal cancer. Fam. Cancer. 11, 525-528.
23. Munger, K., Phelps, W.C., Bubb, V., Howley, P.M. and Schlegel, R. (1989) The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J. Virol, 63, 4417-4421.
24. Hawley-Nelson, P., Vousden, K.H., Hubbert, N.L., Lowy, D.R. and Schiller, J.T. (1989) HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J., 8, 3905-3910.
25. Morley, S.M., Dundas, S.R., James, J.L., Gupta, T., Brown, R.A., Sexton, C.J., Navsaria, H.A., Leigh, I.M. and Lane, E.B. (1995) Temperature sensitivity of the keratin cytoskeleton and delayed spreading of keratinocyte lines derived from EBS patients. J. Cell Sci., 108, 3463-3471.
26. Morley, S.M., D'Alessandro, M., Sexton, C., Rugg, E.L., Navsaria, H., Shemanko, C.S., Huber, M., Hohl, D., Heagerty, A.I., Leigh, I.M. et al. (2003) Generation and characterization of epidermolysis bullosa simplex cell lines: scratch assays show faster migration with disruptive keratin mutations. Br. J. Dermatol., 149, 46-58.
27. Brooke, M.A., Nitoiu, D. and Kelsell, D.P. (2012) Cell-cell connectivity: desmosomes and disease. J. Pathol., 226, 158-171.
28. Nava, P., Laukoetter, M.G., Hopkins, A.M., Laur, O., Gerner-Smidt, K., Green, K.J., Parkos, C.A. and Nusrat, A. (2007) Desmoglein-2: a novel regulator of apoptosis in the intestinal epithelium. Mol. Biol. Cell, 18, 4565-4578.
29. Lorch, J.H., Klessner, J., Park, J.K., Getsios, S., Wu, Y.L., Stack, M.S. and Green, K.J. (2004) Epidermal growth factor receptor inhibition promotes desmosome assembly and strengthens intercellular adhesion in squamous cell carcinoma cells. J. Biol. Chem., 279, 37191-37200.
30. Brennan, D. and Mahoney, M.G. (2009) Increased expression of Dsg2 in malignant skin carcinomas: a tissue-microarray based study. Cell Adhes. Migrat., 3, 148-154.
31. Maretzky, T., McIlwain, D.R., Issuree, P.D., Li, X., Malapeira, J., Amin, S., Lang, P.A., Mak, T.W. and Blobel, C.P. (2013) iRhom2 controls the substrate selectivity of stimulated ADAM17-dependent ectodomain shedding. Proc. Natl. Acad. Sci. USA, 110, 11433-11438.
32. Sahin, U. and Blobel, C.P. (2007) Ectodomain shedding of the EGF-receptor ligand epigen is mediated by ADAM17. FEBS Lett., 581, 41-44.
33. Pastore, S., Mascia, F., Mariani, V. and Girolomoni, G. (2008) The epidermal growth factor receptor system in skin repair and inflammation. J. Invest. Dermatol., 128, 1365-1374.
34. Piepkorn, M., Lo, C. and Plowman, G. (1994) Amphiregulin-dependent proliferation of cultured human keratinocytes: autocrine growth, the effects of exogenous recombinant cytokine, and apparent requirement for heparin-like glycosaminoglycans. J. Cell. Physiol., 159, 114-120.
35. Elder, J.T., Fisher, G.J., Lindquist, P.B., Bennett, G.L., Pittelkow, M.R., Coffey, R.J. Jr, Ellingsworth, L., Derynck, R. and Voorhees, J.J. (1989) Overexpression of transforming growth factor alpha in psoriatic epidermis. Science, 243, 811-814.
36. Zheng, Y., Peng, Z., Wang, Y., Tan, S., Xi, Y. and Wang, G. (2003) Alteration and significance of heparin-binding epidermal-growth-factor-like growth factor in psoriatic epidermis. Dermatology, 207, 22-27.
37. Piepkorn, M. (1996) Overexpression of amphiregulin, a major autocrine growth factor for cultured human keratinocytes, in hyperproliferative skin diseases. Am. J. Dermatopathol., 18, 165-171.
38. Nanney, L.B., Stoscheck, C.M., Magid, M. and King, L.E. Jr. (1986) Altered [125I]epidermal growth factor binding and receptor distribution in psoriasis. J. Invest. Dermatol., 86, 260-265.
39. Dominey, A.M., Wang, X.J., King, L.E. Jr, Nanney, L.B., Gagne, T.A., Sellheyer, K., Bundman, D.S., Longley, M.A., Rothnagel, J.A., Greenhalgh, D.A. et al. (1993) Targeted overexpression of transforming growth factor alpha in the epidermis of transgenic mice elicits hyperplasia, hyperkeratosis, and spontaneous, squamous papillomas. Cell Growth Diff., 4, 1071-1082.
40. Rittie, L., Varani, J., Kang, S., Voorhees, J.J. and Fisher, G.J. (2006) Retinoid-induced epidermal hyperplasia is mediated by epidermal growth factor receptor activation via specific induction of its ligands heparin-binding EGF and amphiregulin in human skin in vivo. J. Invest. Dermatol., 126, 732-739.
41. Stoll, S.W. and Elder, J.T. (1998) Retinoid regulation of heparin-binding EGF-like growth factor gene expression in human keratinocytes and skin. Experim. Dermatol., 7, 391-397.
42. Barrientos, S., Stojadinovic, O., Golinko, M.S., Brem, H. and Tomic-Canic, M. (2008) Growth factors and cytokines in wound healing. Wound Repair Regen., 16, 585-601.
43. Repertinger, S.K., Campagnaro, E., Fuhrman, J., El-Abaseri, T., Yuspa, S.H. and Hansen, L.A. (2004) EGFR enhances early healing after cutaneous incisional wounding. J. Invest. Dermatol., 123, 982-989.
44. Tokumaru, S., Higashiyama, S., Endo, T., Nakagawa, T., Miyagawa, J.I., Yamamori, K., Hanakawa, Y., Ohmoto, H., Yoshino, K., Shirakata, Y. et al. (2000) Ectodomain shedding of epidermal growth factor receptor ligands is required for keratinocyte migration in cutaneous wound healing. J. Cell Biol., 151, 209-220.
45. Li, Y., Fan, J., Chen, M., Li, W. and Woodley, D.T. (2006) Transforming growth factor-alpha: a major human serum factor that promotes human keratinocyte migration. J. Invest. Dermatol., 126, 2096-2105.
46. Cha, D., O'Brien, P., O'Toole, E.A., Woodley, D.T. and Hudson, L.G. (1996) Enhanced modulation of keratinocyte motility by transforming growth factor-alpha (TGF-alpha) relative to epidermal growth factor (EGF). J. Invest. Dermatol., 106, 590-597.
47. Hashimoto, K., Higashiyama, S., Asada, H., Hashimura, E., Kobayashi, T., Sudo, K., Nakagawa, T., Damm, D., Yoshikawa, K. and Taniguchi, N. (1994) Heparin-binding epidermal growth factor-like growth factor is an autocrine growth factor for human keratinocytes. J. Biol. Chem., 269, 20060-20066.
48. Tolino, M.A., Block, E.R. and Klarlund, J.K. (2011) Brief treatment with heparin-binding EGF-like growth factor, but not with EGF, is sufficient to accelerate epithelial wound healing. Biochim. Biophys. Acta., 1810, 875-878.
49. Shirakata, Y., Kimura, R., Nanba, D., Iwamoto, R., Tokumaru, S., Morimoto, C., Yokota, K., Nakamura, M., Sayama, K., Mekada, E. et al. (2005) Heparin-binding EGF-like growth factor accelerates keratinocyte migration and skin wound healing. J. Cell Sci., 118, 2363-2370.
50. Enzinger, P.C. and Mayer, R.J. (2003) Esophageal cancer. N. Engl. J. Med., 349, 2241-2252.
51. Gibault, L., Metges, J.P., Conan-Charlet, V., Lozac'h, P., Robaszkiewicz, M., Bessaguet, C., Lagarde, N. and Volant,A. (2005) DiffuseEGFRstaining is associated with reduced overall survival in locally advanced oesophageal squamous cell cancer. Br. J. Cancer, 93, 107-115.
52. Abedi-Ardekani, B., Dar, N.A., Mir, M.M., Zargar, S.A., Lone, M.M., Martel-Planche, G., Villar, S., Mounawar, M., Saidi, F., Malekzadeh, R. et al. (2012) Epidermal growth factor receptor (EGFR) mutations and expression in squamous cell carcinoma of the esophagus in central Asia. BMC Cancer, 12, 602.
53. Itakura, Y., Sasano, H., Shiga, C., Furukawa, Y., Shiga, K., Mori, S. and Nagura, H. (1994) Epidermal growth factor receptor overexpression in esophageal carcinoma. An immunohistochemical study correlated with clinicopathologic findings and DNA amplification. Cancer, 74, 795-804.
54. Kitagawa, Y., Ueda, M., Ando, N., Ozawa, S., Shimizu, N. and Kitajima, M. (1996) Further evidence for prognostic significance of epidermal growth factor receptor gene amplification in patients with esophageal squamous cell carcinoma. Clin. Cancer Res., 2, 909-914.
55. Hanawa, M., Suzuki, S., Dobashi, Y., Yamane, T., Kono, K., Enomoto, N. and Ooi, A. (2006) EGFR protein overexpression and gene amplification in squamous cell carcinomas of the esophagus. Int. J. Cancer, 118, 1173-1180.
56. Okines, A., Cunningham, D. and Chau, I. (2011) Targeting the humanEGFR family in esophagogastric cancer. Nat. Revi. Clin. Oncol., 8, 492-503.
57. Yamabuki, T., Daigo, Y., Kato, T., Hayama, S., Tsunoda, T., Miyamoto, M., Ito, T., Fujita, M., Hosokawa, M., Kondo, S. et al. (2006) Genome-wide gene expression profile analysis of esophageal squamous cell carcinomas. Int. J. Oncol., 28, 1375-1384.
58. Rittie, L., Kansra, S., Stoll, S.W., Li, Y., Gudjonsson, J.E., Shao, Y., Michael, L.E., Fisher, G.J., Johnson, T.M. and Elder, J.T. (2007) Differential ErbB1 signaling in squamous cell versus basal cell carcinoma of the skin. Am. J. Pathol., 170, 2089-2099.
59. Cataisson, C., Salcedo, R., Hakim, S., Moffitt, B.A., Wright, L., Yi, M., Stephens, R., Dai, R.M., Lyakh, L., Schenten, D. et al. (2012) IL-1R-MyD88 signaling in keratinocyte transformation and carcinogenesis. J. Exp. Med., 209, 1689-1702.
60. Fujimoto, N., Wislez, M., Zhang, J., Iwanaga, K., Dackor, J., Hanna, A.E., Kalyankrishna, S., Cody, D.D., Price, R.E., Sato, M. et al. (2005) High expression of ErbB family members and their ligands in lung adenocarcinomas that are sensitive to inhibition of epidermal growth factor receptor. Cancer Res., 65, 11478-11485.
61. Tsai, S.T., Yang, K.Y., Jin, Y.T., Lin, Y.C., Chang, M.T. and Wu, L.W. (2006) Amphiregulin as a tumor promoter for oral squamous cell carcinoma: involvement of cyclooxygenase 2. Oral Oncol., 42, 381-390.
62. Rubin Grandis, J., Melhem, M.F., Gooding, W.E., Day, R., Holst, V.A., Wagener, M.M., Drenning, S.D. and Tweardy, D.J. (1998) Levels of TGF-alpha andEGFRprotein in head and neck squamous cell carcinoma and patient survival. J. Natl. Cancer Inst., 90, 824-832.
63. Liu, H.B., Yang, Q.C., Shen, Y., Zhu, Y., Zhang, X.J. and Chen, H. (2013) Clinicopathological and prognostic significance of the expression of ADAM17 mRNA and protein in esophageal squamous cell carcinoma. Zhonghua Zhong Liu Za Zhi, 35, 361-365.
64. Singer, A.J. and Clark, R.A. (1999) Cutaneous wound healing. N. Engl. J. Med., 341, 738-746.
65. Finnerty, C.C., Herndon, D.N., Przkora, R., Pereira, C.T., Oliveira, H.M., Queiroz, D.M., Rocha, A.M. and Jeschke, M.G. (2006) Cytokine expression profile over time in severely burned pediatric patients. Shock, 26, 13-19.
66. Grellner, W., Georg, T. and Wilske, J. (2000) Quantitative analysis of proinflammatory cytokines (IL-1beta, IL-6, TNF-alpha) in human skin wounds. Forensic Sci. Int., 113, 251-264.
67. Gallucci, R.M., Sloan, D.K., Heck, J.M., Murray, A.R. and O'Dell, S.J. (2004) Interleukin 6 indirectly induces keratinocyte migration. J. Invest. Dermatol., 122, 764-772.
68. Sato, M., Sawamura, D., Ina, S., Yaguchi, T., Hanada, K. and Hashimoto, I. (1999) In vivo introduction of the interleukin 6 gene into human keratinocytes: induction of epidermal proliferation by the fully spliced form of interleukin 6, but not by the alternatively spliced form. Arch. Dermatol. Res., 291, 400-404.
69. Jiang, W.G., Sanders, A.J., Ruge, F. and Harding, K.G. (2012) Influence of interleukin-8 (IL-8) and IL-8 receptors on the migration of human keratinocytes, the role of PLC-gamma and potential clinical implications. Experim. Therapeut. Med., 3, 231-236.
70. Rennekampff, H.O., Hansbrough, J.F., Kiessig, V., Dore, C., Sticherling, M. and Schroder, J.M. (2000) Bioactive interleukin-8 is expressed in wounds and enhances wound healing. J. Surg. Res., 93, 41-54.
71. Hwang, Y.S., Lee, S.K., Park, K.K. and Chung, W.Y. (2012) Secretion of IL-6 and IL-8 from lysophosphatidic acid-stimulated oral squamous cell carcinoma promotes osteoclastogenesis and bone resorption. Oral Oncol., 48, 40-48.
72. Alberti, C., Pinciroli, P., Valeri, B., Ferri, R., Ditto, A., Umezawa, K., Sensi, M., Canevari, S. and Tomassetti, A. (2012) Ligand-dependent EGFR activation induces the co-expression of IL-6andPAI-1 via theNFkBpathway in advanced-stage epithelial ovarian cancer. Oncogene, 31, 4139-4149.
73. Getsios, S., Simpson, C.L., Kojima, S., Harmon, R., Sheu, L.J., Dusek, R.L., Cornwell, M. and Green, K.J. (2009) Desmoglein 1-dependent suppression of EGFR signaling promotes epidermal differentiation and morphogenesis. J. Cell Biol., 185, 1243-1258.
74. Simpson, C.L., Kojima, S. and Getsios, S. (2010) RNA interference in keratinocytes and an organotypic model of human epidermis. Meth. Mol. Biol., 585, 127-146.
75. Kaplan, N., Fatima, A., Peng, H., Bryar, P.J., Lavker, R.M. and Getsios, S. (2012) EphA2/Ephrin-A1 signaling complexes restrict corneal epithelial cell migration. Invest. Ophthalmol. Vis. Sci., 53, 936-945.
76. Livak, K.J. and Schmittgen, T.D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25, 402-408.
77. Raghunath, M., Hennies, H.C., Velten, F., Wiebe, V., Steinert, P.M., Reis, A. and Traupe, H. (1998) A novel in situ method for the detection of deficient transglutaminase activity in the skin. Arch. Dermatol. Res., 290, 621-627.